GlaxoSmithKline Bexsero achieves primary and secondary endpoints with reduced 3-dose schedule in safety and immunogenicity study in infants and children
GSK presented new data for its meningococcal group B vaccine, Bexsero®,1 comparing safety and immunogenicity with different dosing schedules in infants and young...
European Union approves Alprolix (rFIXFc) for the Treatment of Haemophilia B
Swedish Orphan Biovitrum AB and Biogen announced that the European Commission (EC) has approved Alprolix® (rFIXFc), their extended half-life therapy, for the treatment of...
European Union approves Alprolix (rFIXFc) for the Treatment of Haemophilia B
Swedish Orphan Biovitrum AB and Biogen announced that the European Commission (EC) has approved Alprolix® (rFIXFc), their extended half-life therapy, for the treatment of...
Merck Showcases New Innovations at Analytica 2016
Merck, a leading science and technology company, will exhibit a new range of products and solutions at Analytica 2016, the international trade fair for...
Merck Launches First Commercially Available Equine-Specific Multiplex Assay for Protein Biomarkers
• Detects biomarkers of horse infection, inflammation, immune response and general health • Addresses unmet needs of equine research centers, veterinary research and...
Pfizer Gets Europe Approval For New Multi-Dose Vial Vaccine
fizer Inc announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) approved a new four-dose, multi-dose...
AstraZeneca completes divestment of Imdur to China Medical System Holdings
AstraZeneca announced that it has completed the divestment of the global rights to Imdur, outside the US, to China Medical System Holdings Ltd and...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...